Healthcare Cold Chain Logistics Market Report 2025-2035

The Healthcare Cold Chain Logistics Market Report 2025-2035: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Focus on Drug Development including Personalised Therapies and Biologics Driving the Market Growth

As drug development increasingly focuses on stratified patient populations and personalized medicine, distribution networks are becoming more intricate. For instance, patient stratification testing results in a higher volume of patient samples being transported to central laboratories, while some personalized therapies such as regenerative medicine products require the manipulation of patient samples at designated sites away from the clinical trial location. These factors are driving significant demand for specialized cold chain logistics solutions, reinforcing the sector's growth as biological therapies continue to gain prominence.

The growing pipeline of biological therapies and the shift toward targeting stratified patient populations are key trends shaping the healthcare cold chain logistics market this decade. According to the FDA, the Center for Drug Evaluation and Research (CDER) approved 50 novel treatments in 2025, spanning small molecules, biologics, and oligonucleotide therapeutics. The ten-year rolling average for new drug approvals now stands at 46.5 per year. Additionally, the Center for Biologics Evaluation and Research (CBER) granted 24 biological device approvals, 17 biologics license applications, and 26 biologics license application supplements, underscoring the expanding role of biologics in modern drug development.

High Cost of Healthcare Cold Storage and Transportation to Hamper Industry Growth

This detailed breakdown highlights the high costs associated with cold chain logistics for biologics, vaccines, and other pharmaceuticals, making affordability a significant challenge for healthcare providers and patients. Specialized packaging, such as temperature-controlled containers from Pelican BioThermal, is essential for maintaining product integrity but comes at a premium due to advanced insulation and monitoring technology. These containers, costing between US$200 and US$2,000 per unit, significantly add to logistics expenses.

Furthermore, temperature-monitoring devices, including data loggers for about US$100 US$500 per unit and real-time monitoring systems for US$200 US$1,000 per unit, are critical but further drive up costs. In addition to packaging, transportation costs are another major factor. Cryogenic shipping containers range from US$500 to US$5,000 per unit, depending on the level of temperature control required. Additional expenses arise from regulatory compliance, handling, and safety measures, which fluctuate based on shipping distance, volume, and logistical complexity.

What Questions Should You Ask before Buying a Market Research Report?

• How is the healthcare cold chain logistics market evolving?
• What is driving and restraining the healthcare cold chain logistics market?
• How will each healthcare cold chain logistics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
• How will the market shares for each healthcare cold chain logistics submarket develop from 2025 to 2035?
• What will be the main driver for the overall market from 2025 to 2035?
• Will leading healthcare cold chain logistics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
• Who are the leading players and what are their prospects over the forecast period?
• What are the healthcare cold chain logistics projects for these leading companies?
• How will the industry evolve during the period between 2025 and 2035? What are the implications of healthcare cold chain logistics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the healthcare cold chain logistics market?
• Where is the healthcare cold chain logistics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the healthcare cold chain logistics market today, and over the next 10 years:

• Our 344-page report provides 135 tables and 189 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising healthcare cold chain logistics prices and recent developments.

Segments Covered in the Report

Product

• Biopharmaceuticals
• Vaccines
• Clinical Trial Materials
• Others

Services

• Transportation
• Storage
• Packaging
• Others

Mode of Transport

• Air Transport
• Ground Transport
• Water Transport

Holding Temperature Range

• Cryogenic
• Refrigerated
• Ambient
• Frozen

End-users

• Biopharmaceutical and Biotechnology Companies
• Hospitals and Clinics
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Denmark
• Rest of Europe

Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Argentina
• Rest of Latin America

MEA

• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Healthcare Cold Chain Logistics Market, 2025 to 2035, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

• A.P. Moller Maersk
• Atelerix Ltd
• Cavalier Logistics Inc.
• Catalent, Inc.
• Cardinal Health
• Cencora, Inc.
• CEVA Logistics
• DB Schenker
• Delhivery Limited
• DHL Group
• FedEx
• Kuehne+Nagel
• Marken (A UPS Company)
• NMDP BioTherapies
• Thermo Fisher Scientific Inc.
• United Parcel Services (UPS)
• YUSEN LOGISTICS CO., LTD.

Overall world revenue for Healthcare Cold Chain Logistics Market, 2025 to 2035 in terms of value the market will surpass US$25 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Healthcare Cold Chain Logistics Market, 2025 to 2035 report help you?

In summary, our 344+ page report provides you with the following knowledge:

• Revenue forecasts to 2035 for Healthcare Cold Chain Logistics Market, 2025 to 2035, with forecasts for product, services, mode of transport, holding temperature range, and end-users, each forecast at a global and regional level – discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2035 for five regional and 25 key national markets – See forecasts for the Healthcare Cold Chain Logistics Market, 2025 to 2035 in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 17 of the major companies involved in the Healthcare Cold Chain Logistics Market, 2025 to 2035.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.